García RMT, Medina VI, Durán MC, Alba RE, Beirana PA, García VA, Guevara SE, Lara ML, López CYI, Maldonado CG, Palacios LC, Ramos GLI, Rincón PC, Sánchez CME, Toledo BM, Trevizo OL, Sáez OMM

Language: Spanish
References: 29
Page: 245-255
PDF size: 206.02 Kb.

ABSTRACT

Introduction: atopic dermatitis (AD) is a very frequent, chronic, multifactorial inflammatory skin disease. Therapeutic patient education (TPE) is a patient-centered process that implies the transfer of necessary information and skills to manage disease effectively.
Objectives: should be included in tpe interventions for patients with ad.
Material and methods: an expert consensus using Delphi panel methodology was performed. Pediatric dermatologists and dermatologists with previous experience using TPE for ad were included. Consensus was achieved if ≥80% experts evaluated declarations in the upper tertile of a Likert scale; four rounds of evaluation were held and, after each one, results were presented using descriptive statistics and graphics. Declarations where consensus was not achieved, were evaluated/ modified according to experts’ comments, and were added in the following round.
Results: We included 16 pediatric dermatologists/dermatologist in the expert panel. Thirty-one questions were formulated based on existing literature about the use of TPE in ad and sent to experts. On subsequent rounds, declarations constructed with the answers to these questions were evaluated. A docu ment with all 19 recommendations obtained through consensus that should be included in tpe interventions for ad was made.
Conclusions: tpe is essential for the medical care of patients with ad. It should include explanations about physiopathology, general skin care measures and lifestyle changes, and existing treatments.

REFERENCES

1. LeBovidge J, Borok J, Udkoff J, Yosipovitch G y Eichenfield LF, Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care, Semin Cutan Med Surg 2017; 36(3):131-6.

2. Lagger G, Pataky Z y Golay A, Efficacy of therapeutic education in chronic diseases and obesity, Patient Educ Couns 2010; 79(3):283-6.

3. Fink A, Kosecoff J, Chassin M y Brook RH, Consensus methods: characteristics and guidelines for use, Am J Public Health 1984; 74(9):979-83.

4. De Bes J, Legierse CM, Prinsen CA y De Korte J, Patient education in chronic skin diseases: a systematic review, Acta Derm Venereol 2011; 91(1):12-7.

5. Barbarot S, Bernier C, Deleuran M, De Raeve L, Eichenfield L, El Hachem M et al., Therapeutic patient education in children with atop- ic dermatitis: position paper on objectives and recommendations, Pediatr Dermatol 2013; 30(2):199-206.

6. Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J et al., Consensus development methods, and their use in clinical guideline development, Health Technol Assess 1998; 2(3):1-88.

7. De Villiers MR, De Villiers PJ y Kent AP, The Delphi technique in health sciences education research, Med Teach 2005; 27(7):639-43.

8. Long CC, Funnell CM, Collard R y Finlay AY, What do members of the National Eczema Society really want?, Clin Exp Dermatol 1993; 18(6):516-22.

9. Broberg A, Kalimo K, Lindblad B y Swanbeck G, Parental education in the treatment of childhood atopic eczema, Acta Derm Venereol (Estocolmo) 1990; 70(6):495-9.

10. Cork MJ, Britton J, Butler L, Young S, Murphy R y Keohane SG, Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse, Br J Dermatol 2003; 149(3):582-9.

11. Murray E, Charles C y Gafni A, Shared decision-making in primary care: tailoring the Charles et al. model to fit the context of general practice, Patient Educ Counsel 2006; 62(2);205-11.

12. Richards T, Partnership with patients, Br Med J 1998; 316(7125):85-6.

13. Grossman SK, Schut C, Kupfer J, Valdés-Rodríguez R, Gieier U y Yosipovitch G, Experiences with the first eczema school in the United States, Clin Dermatol 2018; 36(5):662-7.

14. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al., Guidelines for treatment of atopic eczema (atopic dermatitis) part i. J Eur Acad Dermatol Venereol 2012; 26(8):1045-60.

15. Werfel T y Breuer K, Role of food allergy in atopic dermatitis, Curr Opin Allergy Clin Immunol 2004; 4(5):379-85.

16. Liang Y, Tian J, Shen CP, Xu F, Wang H, Li P et al., Therapeutic patient education in children with moderate to severe atopic dermatitis: a multicenter randomized controlled trial in China, Pediatr Dermatol 2018; 35(1):70-5.

17. Gittler JK, Wang JF y Orlow SJ, Bathing and associated treatments in atopic dermatitis, Am J Clin Dermatol 2017; 18(1):45-57.

18. Sarre ME, Martin L, Moote W, Mazza JA y Annweiler C, Are baths desirable in atopic dermatitis?, J Eur Acad Dermatol Venereol 2015; 29(7):1265-74.

19. Kupfer J, Gieler U, Diepgen TL, Fartasch M, Lob-Corzilius T, Ring J et al., Structured education program improves the coping with atopic dermatitis in children and their parents: a multicenter, randomized controlled trial, J Psychosom Res 2010; 68(4):353-8.

20. Melin L, Frederiksen T, Noren P y Swebilius BG, Behavioural treatment of scratching in patients with atopic dermatitis, Br J Dermatol 1986; 115(4):467-74.

21. Suárez AL, Feramisco JD, Koo J y Steinhoff M, Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates, Acta Derm Venereol 2012; 92(1):7-15.

22. Grimalt R, Mengeaud V y Cambazard F, Study Investigators’ Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study, Dermatology 2007; 214(1): 61-7.

23. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A et al., Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part i, J Eur Acad Dermatol Venereol 2018; 32(5):657-82.

24. Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, etfad/ eadv eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients, J Eur Acad Dermatol Venereol 2016; 30(5): 729-47.

25. Mayba JN y Gooderham MJ, Review of atopic dermatitis and topical therapies, J Cutan Med Surg 2017; 21(3):227-36.

26. Katoh N, Ohyva Y, Ikeda M, Ebihara T, Katayama I y Saeki H, Japanese guidelines for atopic dermatitis 2020, Allergol Int 2020. doi:10.1016/j. alit.2020.02.006.

27. Müller SM, Tomaschett D, Euler S, Vogt DR, Herzog L e Itin P, Topical corticosteroid concerns in dermatological outpatients: a crosssectional and interventional study, Dermatology 2016; 232(4):444-52.

28. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A et al., Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part ii, J Eur Acad Dermatol Venereol 2018; 32(6):850-78.

29. LeBovidge JS, Elverson W, Timmons KG, Hawryluk EB, Rea C, Lee M et al., Multidisciplinary interventions in the management of atopic dermatitis, J Allergy Clin Immunol 2016; 138(2):325-34.